Have a personal or library account? Click to login
Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma Cover

Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma

Radiology and Oncology
Volume 41 (2007): Issue 1 (March 2007)
By: Barbara Novaković,  Vladimir Kotnik,  Tanja Šetina,  Marjeta Vovk and  Srdjan Novaković  
Open Access
|Apr 2007
DOI: https://doi.org/10.2478/v10019-007-0004-y | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 23 - 32
Published on: Apr 30, 2007
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
lymphoma,
B-cell - therapy,
antigens,
CD 20,
antibodies,
monoclonal
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2007 Barbara Novaković, Vladimir Kotnik, Tanja Šetina, Marjeta Vovk, Srdjan Novaković, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 41 (2007): Issue 1 (March 2007)